Advertisement News Archives - Page 3111 of 5237 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

September 21, 2026

Telix to acquire ITM in deal worth up to $2.35bn

Australia-based Telix Pharmaceuticals has agreed to acquire ITM Isotope Technologies Munich in a transaction valued at up to $2.35bn, combining Telix’s operations with ITM’s radioisotope production business and late-stage treatment candidate ITM-11.

Telix to acquire ITM in deal worth up to $2.35bn